![Anthony Gibney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Gibney
Director/Board Member at
INFLARX N.V.
Net worth: 2 M $ as of 2026-07-30
Profile
Anthony S.
Gibney is an Independent Non-Executive Director at InflaRx NV since 2021 and a Director at LAPIX Therapeutics, Inc. since 2024.
Former roles include Chairman at Clearside Biomedical, Inc. from 2024 to 2025, Director at InflaRx GmbH, Managing Director-Global Healthcare Group at Merrill Lynch & Co., Inc. from 1999 to 2009, Independent Non-Executive Director at InflaRx NV from 2018 to 2019, Associate-Healthcare Investment Banking Group at Lehman Brothers, Inc. from 1993 to 1999, Chief Business Officer & Executive Vice President at Achillion Pharmaceuticals, Inc. from 2018 to 2020, MD & Co-Head-Biotechnology Investment Team at Leerink Partners LLC from 2009 to 2017, Executive VP, Chief Business & Strategy Officer at IVERIC bio, Inc. from 2021 to 2023, Chief Financial & Business Officer at Parabilis Medicines, Inc. from 2020 to 2021, and Chief Financial & Business Officer at Aura Biosciences, Inc. from 2025 to 2026.
Education includes an undergraduate degree from Yale University conferred in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.26% | 2026-06-15 | 265,354 ( 0.26% ) | 2 M $ | 2026-07-30 |
INFLARX N.V. 0.01% | 2026-03-17 | 10,000 ( 0.01% ) | 17 000 $ | 2026-07-30 |
Anthony Gibney active positions
| Companies | Position | Start |
|---|---|---|
| INFLARX N.V. | Director/Board Member | 2021-05-18 |
Lapix Therapeutics, Inc.
 Lapix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for autoimmune diseases and oncology | Director/Board Member | 2023-12-31 |
Former positions of Anthony Gibney
| Companies | Position | End |
|---|---|---|
| AURA BIOSCIENCES, INC. | Director of Finance/CFO | 2026-08-10 |
| CLEARSIDE BIOMEDICAL | Chairman | 2025-08-10 |
| IVERIC BIO, INC. | Corporate Officer/Principal | 2023-06-30 |
| PARABILIS MEDICINES, INC. | Director of Finance/CFO | 2021-11-30 |
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-01-27 |
Training of Anthony Gibney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology Operates as a biotech company which develops new therapeutics in the field of inflammation | Health Technology |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Lapix Therapeutics, Inc.
Lapix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for autoimmune diseases and oncology | Health Technology |
- Stock Market
- Insiders
- Anthony Gibney
